UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Phase I Clinical and Pharmacological Evaluation of Sodium Phenylbutyrate on an 120-h Infusion Schedule

Clinical cancer research, 2001-10, Vol.7 (10), p.3047-3055

2001

Volltextzugriff (PDF)

Impact of Prolonged Infusions of the Putative Differentiating Agent Sodium Phenylbutyrate on Myelodysplastic Syndromes and Acute Myeloid Leukemia

Clinical cancer research, 2002-04, Vol.8 (4), p.963-970

2002

Volltextzugriff (PDF)

Impact of the Putative Differentiating Agent Sodium Phenylbutyrate on Myelodysplastic Syndromes and Acute Myeloid Leukemia

Clinical cancer research, 2001-08, Vol.7 (8), p.2330-2339

2001

Volltextzugriff (PDF)

Role of Body Surface Area in Dosing of Investigational Anticancer Agents in Adults, 1991–2001

JNCI : Journal of the National Cancer Institute, 2002-12, Vol.94 (24), p.1883-1888

2002

Volltextzugriff (PDF)

Toxicity, Efficacy, and Pharmacology of Suramin in Adults With Recurrent High-Grade Gliomas

Journal of clinical oncology, 2001-07, Vol.19 (13), p.3260-3266

2001

Volltextzugriff (PDF)

Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival

International journal of radiation oncology, biology, physics, 2000-11, Vol.48 (4), p.1089-1096

2000

Volltextzugriff (PDF)

A Phase I and Pharmacologic Evaluation of the DNA Intercalator CI-958 in Patients with Advanced Solid Tumors

Clinical cancer research, 2000-10, Vol.6 (10), p.3885-3894

2000

Volltextzugriff (PDF)

Should pancreaticoduodenectomy be performed in octogenarians?

Journal of gastrointestinal surgery, 1998-05, Vol.2 (3), p.207-216

1998

Volltextzugriff (PDF)

Population Pharmacokinetic Model for Topotecan Derived From Phase I Clinical Trials

Journal of clinical oncology, 2000-06, Vol.18 (12), p.2459-2467

2000

Volltextzugriff (PDF)

Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks

Cancer research (Chicago, Ill.), 1994-01, Vol.54 (2), p.427-436

1994

Volltextzugriff (PDF)

Phase I and Pharmacologic Study of Oral Fluorouracil on a Chronic Daily Schedule in Combination With the Dihydropyrimidine Dehydrogenase Inactivator Eniluracil

Journal of clinical oncology, 2000-02, Vol.18 (4), p.915-926

2000

Volltextzugriff (PDF)

Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels

International journal of radiation oncology, biology, physics, 1999-07, Vol.44 (5), p.1039-1046

1999

Volltextzugriff (PDF)

Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864); a new camptothecin analogue

Cancer research (Chicago, Ill.), 1992-04, Vol.52 (8), p.2268-2278

1992

Volltextzugriff (PDF)

Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation

Drug metabolism and disposition, 1997-05, Vol.25 (5), p.544

1997

Volltextzugriff (PDF)

Parenteral busulfan: Is therapeutic monitoring still warranted?

Biology of blood and marrow transplantation, 2002-01, Vol.8 (9), p.465-467

Grochow, Louise B

2002

Volltextzugriff (PDF)

Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation

Cancer research (Chicago, Ill.), 1995-02, Vol.55 (4), p.810-816

1995

Volltextzugriff (PDF)

Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes

Annals of surgery, 1997-09, Vol.226 (3), p.248-260

1997

Volltextzugriff (PDF)

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience

Annals of surgery, 1997-05, Vol.225 (5), p.621-636

1997

Volltextzugriff (PDF)

Prospects for Fertility after Chemotherapy or Radiation for Neoplastic Disease

Fertility and sterility, 1986-04, Vol.45 (4), p.443-459

1986

Volltextzugriff (PDF)

Should Anticancer Drug Doses Be Adjusted in the Obese Patient?

JNCI : Journal of the National Cancer Institute, 1995-03, Vol.87 (5), p.333-334

1995

Volltextzugriff (PDF)

Clinical potential of matrix metalloprotease inhibitors in cancer therapy

Drugs (New York, N.Y.), 2000-05, Vol.59 (5), p.1043-1055

2000

Volltextzugriff (PDF)

A Prospective Pharmacologic Evaluation of Age-Related Toxicity of Adjuvant Chemotherapy in Women with Breast Cancer

Cancer investigation, 2000, Vol.18 (6), p.521-529

2000

Volltextzugriff (PDF)

A phase II trial of topotecan in patients with previously untreated pancreatic cancer

Anti-cancer drugs, 1996-06, Vol.7 (4), p.410-414

1996

Volltextzugriff (PDF)

Cytotoxic Effects of Topotecan Combined With Various Anticancer Agents in Human Cancer Cell Lines

JNCI : Journal of the National Cancer Institute, 1996-06, Vol.88 (11), p.734-741

1996

Volltextzugriff (PDF)

Intrathecal 4-hydroperoxycyclophosphamide : neurotoxicity, cerebrospinal fluid pharmacokinetics and antitumor activity in a rabbit model of VX2 leptomeningeal carcinomatosis

Cancer research (Chicago, Ill.), 1992-11, Vol.52 (22), p.6168-6174

1992

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(85)

Sprache

Englisch
(85)

Erscheinungsjahr

n.n

Thema

Humans
(69)
Science & Technology
(62)
Life Sciences & Biomedicine
(61)
Biological And Medical Sciences
(57)
Medical Sciences
(56)
Pharmacology. Drug Treatments
(51)
Female
(47)
Antineoplastic Agents
(45)
Middle Aged
(44)
Oncology
(44)
Adult
(42)
Male
(42)
Chemotherapy
(40)
Aged
(37)
Dose-Response Relationship, Drug
(21)
Drug Administration Schedule
(18)
Neoplasms - Drug Therapy
(18)
Antineoplastic Agents - Adverse Effects
(15)
Antineoplastic Agents - Therapeutic Use
(15)
Antineoplastic Agents - Pharmacokinetics
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Phase I Clinical and Pharmacological Evaluation of Sodium Phenylbutyrate on an 120-h Infusion Schedule

Impact of Prolonged Infusions of the Putative Differentiating Agent Sodium Phenylbutyrate on Myelodysplastic Syndromes and Acute Myeloid Leukemia

Impact of the Putative Differentiating Agent Sodium Phenylbutyrate on Myelodysplastic Syndromes and Acute Myeloid Leukemia

Role of Body Surface Area in Dosing of Investigational Anticancer Agents in Adults, 1991–2001

Toxicity, Efficacy, and Pharmacology of Suramin in Adults With Recurrent High-Grade Gliomas

Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival

A Phase I and Pharmacologic Evaluation of the DNA Intercalator CI-958 in Patients with Advanced Solid Tumors

Should pancreaticoduodenectomy be performed in octogenarians?

Population Pharmacokinetic Model for Topotecan Derived From Phase I Clinical Trials

Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks

Phase I and Pharmacologic Study of Oral Fluorouracil on a Chronic Daily Schedule in Combination With the Dihydropyrimidine Dehydrogenase Inactivator Eniluracil

Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels

Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864); a new camptothecin analogue

Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation

Parenteral busulfan: Is therapeutic monitoring still warranted?

Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation

Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience

Prospects for Fertility after Chemotherapy or Radiation for Neoplastic Disease

Should Anticancer Drug Doses Be Adjusted in the Obese Patient?

Clinical potential of matrix metalloprotease inhibitors in cancer therapy

A Prospective Pharmacologic Evaluation of Age-Related Toxicity of Adjuvant Chemotherapy in Women with Breast Cancer

A phase II trial of topotecan in patients with previously untreated pancreatic cancer

Cytotoxic Effects of Topotecan Combined With Various Anticancer Agents in Human Cancer Cell Lines

Intrathecal 4-hydroperoxycyclophosphamide : neurotoxicity, cerebrospinal fluid pharmacokinetics and antitumor activity in a rabbit model of VX2 leptomeningeal carcinomatosis

Suchergebnisse filtern